Barron's on MSN30m
Novo’s New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way.
Now, Novo Holdings, Novo’s controlling shareholder, will buy one of the largest contract manufacturers, Catalent, for $16.5 ...